DOI: http://dx.doi.org/10.18203/2319-2003.ijbcp20194784

A comparative study on safety and efficacy of tolperisone with etodolac and thiocolchicoside with etodolac in patients of acute low back pain with musculoskeletal spasm

Tanu Garg, Vijay K. Yadav

Abstract


Background: Low back pain is one of the most common health problems in society which leads to considerable disability, loss of work days, and puts a huge burden on socioeconomic and healthcare system. It is often associated with musculoskeletal spasm. The aim of the study was to compare the efficacy and safety of tolperisone and thiocolchicoside in combination with etodolac in patients of acute low back pain associated with musculoskeletal spasm.

Methods: it was a prospective, randomized, open label study which included patients of either sex between age 18-50 years of acute low back pain with musculoskeletal spasm. Patients were allocated in two groups. Patients in ‘Group A’ were given tolperisone 150 mg + etodolac 400 mg twice a day and patients in ‘Group B’ were given thiocolchicoside 4 mg + etodolac 400 mg twice a day. Efficacy of two drugs was assessed by decrease in finger to floor distance (FFD), decrease in pain as per visual analog scale (VAS) and global assessment of efficacy of treatment by physician. Follow-up of the patients was done on day 3 and 7 of treatment. Various side effects reported by patients in both the groups were also recorded and compared.

Results: Both tolperisone and thiocolchicoside caused significant decrease in FFD, reduced pain score thus indicating decrease in pain and spasm. Side effects reported in both groups were mild and did not result in discontinuation of therapy.

Conclusions: Tolperisone was found to have efficacy similar to that of thiocolchicoside though number of side effects reported was more with tolperisone.


Keywords


Thiocolchicoside, Tolperisone, Acute low back pain, Musculoskeletal spasm

Full Text:

PDF

References


Andersson GB. Epidemiology of low back pain. Acta Orthop Scand Suppl. 1998;281:28–31.

Cohen SP, Argoff CE, Carragee EJ. Management of low back pain. BMJ. 2008;337:a2718.

Everett C Hills. Mechanical low back pain. Medscape 2012. Available at: http://emedicine.medscape. com/article/310353-overview. Accessed on 11 October 2012.

Rao R, Panghate A, Chandanwale A, Sardar I, Ghosh M, Roy M, et al. Clinical comparative study: efficacy and tolerability of tolperisone and thiocolchicoside in acute low back pain and spinal muscle spasticity. Asian Spine J. 2012;6(2):115-22.

Soonawalla DF, Joshi N. Efficacy of thiocolchicoside in Indian patients suffering from low back pain associated with muscle spasm. J Indian Med Assoc. 2008;106(5):331-5.

Bhattacharjya B, Naser SM, Biswas A, Kamal F, Banerjee K. Effectiveness of Tolperisone Hydrochloride with Aceclofenac as combined therapy in acute low back pain. IJPMR. 2012;23(2):74-8.

Prabhoo R, Keny S, Prabhoo T, Singh A, Rana R. A Phase IV observational multi-centre, open-label study on efficacy and safety of tolperisone 150 mg in patients with painful muscle spasm associated with degenerative or inflammatory diseases of the musculoskeletal System. J Assoc Physicians India. 2011;59:33-7.

Ketenci A, Ozcon E, Karamursel S. Assessment of efficacy and psychomotor performances of Thiocolchicoside and Tizanidine in patients with acute low back pain. Int J Clin Pract. 2005;59(7):764-70.

Pratzel HG, Alken RG, Ramm S. Efficacy and tolerance of repeated oral doses of tolperisone hydrochloride in the treatment of painful reflex muscle spasm: results of a prospective placebo-controlled double-blind trial. Pain. 1996;67(2-3):417-25.

Maaz SH, Khandelwal PN, Baig M, Doifode SM, Ghotkar UM. Evaluation of efficacy and tolerability of eperisone and thiocolchicoside in treatment of low back pain associated with muscle spasm: An open label, prospective, randomized controlled trial. Int J Basic Clin Pharmacol. 2016;5(6):2669-74.

Ambrish S, Nagesh Raju G, Dharmaraj B, Nagendra Gowda M R. A Comparative study of efficacy of Thiocolchicoside with Diclofenac vs Eperisone with Diclofenac in patients with back pain. Int J surg Orthop. 2017;3(1):1-5.

Tuzun F, Unalan H, Oner N, Ozgüzel H, Kirazli Y, Icagasioglu A et al. Multicenter, randomized, double-blinded, placebo-controlled trial of thiocolchicoside in acute low back pain. Joint Bone Spine. 2003;70(5):356-61.

Saravanabhavan S, Kuchake V, Al-Saikhan FI. Comparative efficacy and safety of Methocarbamol and Thiocolchicoside in acute low back pain. World J Pharm Pharma Sci. 2014;3(4):276-86.

Vora A. Tolperisone. J Assoc Physicians India. 2010;58:127-8.

Dulin J, Kovacs L, Ramm S, Horvath F, Ebeling L, Kohnen R. Evaluation of sedative effects of single and repeated doses of 50mg and 150mg Tolperisone Hydrochloride. Results of a Prospective, Randomized, Double-blind, Placebo-controlled trial. Pharmacopsychiatry. 1998;31(4):137-42.

Quasthoff S, Mockel C, Zieglgansberger W, Schreibmayer W. Tolperisone: a typical representative of a class of centrally acting muscle relaxants with less sedative side effects. CNS Neurosci Ther. 2008;14(2):107-19.